SCHEMBL2530412

SCHEMBL2530412

[CH2]C[C@H](C)COC(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9756912 0.85 TDP1 (0.48) —
SCHEMBL128407 0.82 TDP1 (0.39) —
SCHEMBL22689608 0.80 TDP1 (0.45) —
SCHEMBL709298 0.78 — —
SCHEMBL12239784 0.78 — —
SCHEMBL17511777 0.78 — —
SCHEMBL2477734 0.78 TDP1 (0.43) —
SCHEMBL2697467 0.78 — —
SCHEMBL9756898 0.78 — —
SCHEMBL309720 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039465-B2 Cytoskeletal active compounds, composition and use INSPIRE PHARMACEUTICALS, INC. (US) 2011-10-18 — — US disclosed
US-20100130572-A1 CYTOSKELETAL ACTIVE COMPOUNDS, COMPOSITION AND USE LAMPE JOHN W 2010-05-27 — — US disclosed
US-7320974-B2 Cytoskeletal active compounds, compositions and use INSPIRE PHARMACEUTICALS, INC. (US) 2008-01-22 — — US disclosed
EP-1866316-A2 CYTOSKELETAL ACTIVE COMPOUNDS, COMPOSITION AND USE Inspire Pharmaceuticals, Inc. (US) 2007-12-19 — — EP disclosed
WO-2006104897-A2 CYTOSKELETAL ACTIVE COMPOUNDS, COMPOSITION AND USE INSPIRE PHARMACEUTICALS, INC. (US) 2006-10-05 — — WO disclosed
US-20060217427-A1 Cytoskeletal active compounds, compositions and use INSPIRE PHARMACEUTICALS, INC. 2006-09-28 — — US disclosed
Send feedback